ReviewFrontiers in microbiology2021

Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine.

Vincent Jean-Pierre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.